Single chemical entity legal highs: assessing the risk for long term harm
CB McNabb, BR Russell, D Caprioli… - Current Drug Abuse …, 2012 - ingentaconnect.com
A recent and dramatic increase in the emergence of novel psychoactive substances ('legal
highs') has left many governments unable to provide a timely response to an increasing …
highs') has left many governments unable to provide a timely response to an increasing …
Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
RO Cook, SB Shrewsbury, NN Ramadan… - US Patent …, 2012 - Google Patents
Pharmaceutical compositions containing dihydroergotamine (DHE) and methods in which
DHE is administered to patients for treatment of migraine without side effects or adverse …
DHE is administered to patients for treatment of migraine without side effects or adverse …
Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
RO Cook, SB Shrewsbury, NN Ramadan… - US Patent …, 2012 - Google Patents
US8148377B2 - Method of therapeutic administration of DHE to enable rapid relief of migraine
while minimizing side effect profile - Google Patents US8148377B2 - Method of therapeutic …
while minimizing side effect profile - Google Patents US8148377B2 - Method of therapeutic …
Pathophysiology of migraine & triptan mechanism of action
RB Halker, BB Vargas - 2012 - Future Medicine
Migraine is a disabling and highly prevalent disorder with a cumulative lifetime incidence of
7.4% in males and 21% in females. Numerous advances have been made in recent years …
7.4% in males and 21% in females. Numerous advances have been made in recent years …